首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到17条相似文献,搜索用时 203 毫秒
1.
为建立体外诱导、培养猪外周血单核细胞来源树突状细胞(DC)的方法,并对其进行免疫生物学特性鉴定,本实验从猪外周血无菌分离单核细胞—DC前体细胞,以猪源重组GM-CSF和IL-4联合诱导培养,从形态学、表型及功能方面对其进行检测。结果证实,经体外诱导培养的猪DC具有典型的树突状形态;培养6d的未成熟DC表面SLA-II-DR、CD1、CD172a表达的阳性率分别为61.50%、83.10%和24.90%;培养8d的成熟DC表面SLA-II-DR、CD1、CD172a表达的阳性率分别为71.70%、50.10%和19.30%;培养的DC具有吞噬异物的功能,以及刺激同种异体淋巴细胞增殖的能力。本文首次在国内成功地建立了体外培养猪外周血单核细胞来源DC的方法,为进一步研究DC在猪传染性疾病致病机制中的作用奠定了基础。  相似文献   

2.
鸡骨髓源树突状细胞体外转化培养   总被引:1,自引:0,他引:1  
为深入探讨家鸡获得性免疫应答的分子机制,本研究探索了体外定向诱导和分化鸡骨源树突状细胞(Dendritic cell,DC)的方法。通过体外分离雏鸡骨髓源细胞,加入重组的鸡粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白介素4(IL-4)定向诱导培养获得大量未成熟DCs,经过接种新城疫病毒(Newcastle disease virus,NDV)而激活,对其进行细胞形态学鉴定。结果表明:诱导4d后,部分细胞由单一的圆形球状逐渐生长呈短梭状;诱导6d后,细胞在40倍镜下可见基本呈短梭状且部分伸出触手;接种NDV后,细胞体积增大,触手伸长,形态趋于成熟,说明已成功建立体外利用细胞因子诱导分化鸡骨髓源DC的方法。  相似文献   

3.
试验旨在建立猪集落刺激因子(granulocyte-macrophage colony stimulating factor,GM-CSF)和白细胞介素-4(interleukin-4,IL-4)的真核表达体系,应用表达的2种细胞因子体外诱导猪树突状细胞并检测其细胞功能。首先构建GM-CSF和IL-4真核表达载体,并在HEK293细胞上进行表达验证;其次应用表达的2种细胞因子诱导猪骨髓源和血液源单核细胞;最后分别采用荧光显微镜、流式细胞术检测猪树突状细胞的表面标志CD1a、SLA-Ⅱ和SWC3a,并进行树突状细胞形态学和免疫学功能鉴定。结果显示,本研究构建的2种真核表达载体在HEK293细胞中成功表达GM-CSF和IL-4。形态学观察发现,细胞因子诱导的单核细胞培养3 d后有聚集现象,6 d时可观察到典型的树突状突起。流式细胞术检测发现,表达的细胞因子可成功诱导猪骨髓源和血液源单核细胞转化为树突状细胞,其SWC3a+/SLA-Ⅱ+和CD1a+/SLA-Ⅱ+双阳性比例显著提高,与商品化细胞因子处理组没有区别。细胞吞噬试验发现,表达的细胞因子诱导的树突状细胞为未成熟树突状细胞,具有很强的细胞吞噬能力。本试验成功建立了在真核细胞中表达猪重组蛋白GM-CSF和IL-4的方法,并联合应用2种重组细胞因子体外诱导获得猪骨髓源和血液源单核树突状细胞,为进一步研究猪树突状细胞与各种病原微生物作用奠定基础。  相似文献   

4.
为了探讨鸡骨髓源树突状细胞(bone marrow-derived dendritic cells, BMDCs)的体外诱导培养方法,并分析鸡树突状细胞(DCs)的主要生物学特性,将用淋巴细胞分离液分离的鸡骨髓细胞经差速贴壁纯化后获得单个核细胞,然后经粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白细胞介素4(IL-4)体外诱导分化,细胞培养后第7天再加入脂多糖(LPS)继续培养48 h刺激成熟,分别于倒置显微镜和电子显微镜下进行形态变化观察,同时应用流式细胞仪对鸡骨髓源树突状细胞表面标志进行分析、鉴定。结果显示鸡骨髓细胞培养7 d后,细胞体积增大,细胞表面长出树突状小突起,细胞表面高表达MHCⅡ和CD11c分子,经LPS刺激后,突起伸长变粗,扫描电镜观察呈典型的树突状细胞形态,细胞表面MHCⅡ表达显著升高,依据上述方法成功获得大量而高纯度的鸡骨髓源树突状细胞,为进一步研究禽类DCs的生物学功能及其在某些疾病发生中的作用奠定了基础。  相似文献   

5.
通过原核表达和镍柱亲和层析获得纯度达95%以上的重组旋毛虫蛋白谷胱甘肽S-转移酶(rTs-GST),相对分子质量26 000。分离小鼠骨髓源树突状细胞(BMDC),体外培养至第7天,加入rTs-GST和rTs-GST+LPS刺激48h后,收集细胞进行流式细胞术和ELISA分析。流式结果显示:rTs-GST可抑制由LPS诱导的树突状细胞(DC)表面MHC-II和CD 86表达率的升高。ELISA结果显示:rTs-GST可促进DC分泌抗炎性细胞因子IL-10和TGF-β;抑制由LPS诱导的促炎性因子TNF-α和IL-1β的分泌。因此,旋毛虫可能通过蛋白谷胱甘肽S-转移酶改变DC活化和成熟,诱导T细胞向Th 2方向发展,从而调节宿主免疫反应达到长期寄生。  相似文献   

6.
《畜牧与兽医》2015,(7):75-79
研究淫羊藿苷(ICA)对小鼠髓源树突状细胞(DC)分化及成熟的影响。小鼠骨髓细胞用GM-NSF和IL-4培养5 d,然后用免疫磁珠法纯化DC细胞,试验组分别加入淫羊藿苷2、5、10和20 mg/m L,空白对照组加等量RPMI-1640,阳性对照组加脂多糖(LPS),6组分别同时作用48 h。流式细胞仪检测CDllc、主要组织相容性复合物(MHC)-Ⅱ类分子及协同刺激分子CD80、CD86表达水平和细胞摄取抗原的能力,ELISA检测产生的细胞因子(IL-2、IL-10、IL-12),混合淋巴细胞反应检测细胞提呈抗原的能力。结果表明:4个添加淫羊藿苷组的CD80、CD86、CDllc、MHC-Ⅱ类分子表达水平均明显高于空白对照组,分泌IL-2、IL-10、IL-12能力比空白对照组增加,吞噬FITC-dextran的能力下降,并可促进同种异基因T细胞的增殖。说明淫羊藿苷可以促进体外培养的小鼠髓源DC的成熟,促进DC诱导的免疫应答启动。  相似文献   

7.
为了探讨鸡骨髓源树突状细胞(bone marrow-derived dendritic cells,BMDCs)的体外诱导培养方法,并分析鸡树突状细胞(DCs)的主要生物学特性,将用淋巴细胞分离液分离的鸡骨髓细胞经差速贴壁纯化后获得单个核细胞,然后经粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白细胞介素4(IL-4)体外诱导分化,细胞培养后第7天再加入脂多糖(LPS)继续培养48 h刺激成熟,分别于倒置显微镜和电子显微镜下进行形态变化观察,同时应用流式细胞仪对鸡骨髓源树突状细胞表面标志进行分析、鉴定。结果显示鸡骨髓细胞培养7 d后,细胞体积增大,细胞表面长出树突状小突起,细胞表面高表达MHCⅡ和CD11c分子,经LPS刺激后,突起伸长变粗,扫描电镜观察呈典型的树突状细胞形态,细胞表面MHCⅡ表达显著升高,依据上述方法成功获得大量而高纯度的鸡骨髓源树突状细胞,为进一步研究禽类DCs的生物学功能及其在某些疾病发生中的作用奠定了基础。  相似文献   

8.
鸡骨髓源树突状细胞的诱导分化及鉴定   总被引:1,自引:0,他引:1  
为建立鸡骨髓源树突状细胞(Dcs)的体外培养和鉴定方法,本研究无菌抽取10日龄健康SPF雏鸡的骨髓,体外分离纯化骨髓细胞,将其培养于含有重组的人粒细胞-巨噬细胞集落刺激因子(rhGM-CSF)和白细胞介素4 (rhIL4)的RPMI 1640营养液中,诱导培养鸡骨髓源DCs.采用显微镜观察其体外培养过程中的形态特征及流...  相似文献   

9.
利用重组鸡粒细胞-巨噬细胞集落刺激因子(chGM-CSF)和重组鸡白细胞介素4(chIL-4)体外诱导鸡骨髓细胞分化为鸡骨髓源树突状细胞(chicken bone marrow-derived dendritic cells,chBMDCs),对诱导条件进行优化,利用鸡巨噬细胞系HD11来源的NDV Ex刺激未成熟ch...  相似文献   

10.
本研究对猪源树突状细胞(dendritic cell,DC)的分化条件进行了摸索,通过对试验猪只日龄的选择、刺激物浓度和刺激时间的比较以及DC表面分子标记的选择,确定了猪外周血和骨髓源DC的分化条件。静脉采集15日龄猪只抗凝血分离获得外周血单核细胞(peripheral blood mononuclear cells,PBMCs),贴壁12 h后,用终浓度80 ng/mL的GM-CSF和40 ng/mL的IL-4共同刺激7 d,用CD152作为DC的表面分子标志,试验结果显示:贴壁的单核细胞在GM-CSF和IL-4的共同刺激下,7 d后能够将超过60%的单核细胞刺激分化为CD152~+的DC。取15日龄猪只的股骨和胫骨并冲洗骨髓腔,参考外周血来源DC的分化方法,结果显示:可以获得约63%的骨髓源单核细胞刺激分化为CD152~+的DC。本研究建立的DC分化方法为进一步研究病毒感染后猪体建立获得性免疫应答的机制奠定了平台基础。  相似文献   

11.
Isolation and characterization of pediatric canine bone marrow CD34+ cells   总被引:4,自引:0,他引:4  
Historically, the dog has been a valuable model for bone marrow transplantation studies, with many of the advances achieved in the dog being directly transferable to human clinical bone marrow transplantation protocols. In addition, dogs are also a source of many well-characterized homologues of human genetic diseases, making them an ideal large animal model in which to evaluate gene therapy protocols. It is generally accepted that progenitor cells for many human hematopoietic cell lineages reside in the CD34+ fraction of cells from bone marrow, cord blood, or peripheral blood. In addition, CD34+ cells are the current targets for human gene therapy of diseases involving the hematopoietic system. In this study, we have isolated and characterized highly enriched populations of canine CD34+ cells isolated from dogs 1 week to 3 months of age. Bone marrow isolated from 2- to 3-week-old dogs contained up to 18% CD34+ cells and this high percentage dropped sharply with age. In in vitro 6-day liquid suspension cultures, CD34+ cells harvested from 3-week-old dogs expanded almost two times more than those from 3-month-old dogs and the cells from younger dogs were also more responsive to human Flt-3 ligand (Flt3L). In culture, the percent and number of CD34+ cells from both ages of dogs dropped sharply between 2 and 4 days, although the number of CD34+ cells at day 6 of culture was higher for cells harvested from the younger dogs. CD34+ cells harvested from both ages of dogs had similar enrichment and depletion values in CFU-GM methylcellulose assays. Canine CD34+/Rho123lo cells expressed c-kit mRNA while the CD34+/Rhohi cells did not. When transplanted to a sub-lethally irradiated recipient, CD34+ cells from 1- to 3-week-old dogs gave rise to both myeloid and lymphoid lineages in the periphery. This study demonstrates that canine CD34+ bone marrow cells have similar in vitro and in vivo characteristics as human CD34+ cells. In addition, ontogeny-related functional differences reported for human CD34+ cells appear to exist in the dog as well, suggesting pediatric CD34+ cells may be better targets for gene transfer than adult bone marrow. The demonstration of similarities between canine and human CD34+ cells enhances the dog as a large, preclinical model to evaluate strategies for improving bone marrow transplantation protocols, for gene therapy protocols that target CD34+ cells, and to study the engraftment potential of various cell populations that may contain hematopoietic progenitor cell activity.  相似文献   

12.
Because of their unsurpassed potency in presenting antigens to naive T cells, dendritic cells are considered to be an important candidate in the development of immunotherapeutic strategies. Despite the high potential of dendritic cell-based immunotherapy, as a so-called dendritic cell vaccination, few clinical approaches using dendritic cell vaccination have been performed in the dog because of very limited information regarding the generation of canine dendritic cells and their functional properties. We therefore established a protocol for the efficient generation of dendritic cells from canine bone marrow cells using recombinant feline granulocyte-macrophage colony-stimulating factor and canine interleukin-4. Dendritic cells were generated efficiently: a yield of 1-9 x 10(6) cells per approximately 0.5 ml of canine bone marrow aspiration was achieved. These dendritic cells showed features shared with mouse and human dendritic cells: dendrite morphology, expression of surface markers MHC class II and CD11c, and up-regulation of molecules related to antigen presentation (MHC class II, B7-1, and B7-2) by activation with lipopolysaccharide. Moreover, the dendritic cells demonstrated phagocytic activity, processing activity of pinocytosed proteins, and activation of allogeneic T cells far more potent than that by macrophages. Our findings suggest that the bone marrow-derived dendritic cells are functional for the capturing and processing of antigens and the initiation of T cell responses.  相似文献   

13.
An 8-year-old castrated male Golden Retriever was evaluated for decreased appetite, lethargy, and labored breathing of 1-week duration. Bilateral pulmonary infiltrates, hepatomegaly, and splenomegaly were present. Results of a CBC revealed marked leukocytosis (62,600/microL; reference interval 4000-15,500/microL) and large numbers of atypical cells (30,700/microL) with abundant cytoplasm. There was no concurrent anemia, neutropenia, or thrombocytopenia. Morphology of the atypical cells was most consistent with a histiocytic origin. Similar cells were identified in bone marrow aspirates, and were morphologically suggestive of the macrophage variant of disseminated histiocytic sarcoma. However, flow cytometry of the abnormal circulating cells revealed CD1c, CD11c, and major histocompatibility complex (MHC) Class II expression without expression of CD11d or lymphoid markers, consistent with myeloid dendritic antigen-presenting cells. At necropsy, the splenic architecture was effaced by neoplastic histiocytes that were also infiltrating lung, liver, an abdominal lymph node, myocardium, an bone marrow. Immunohistochemistry of the splenic neoplastic cells confirmed dendritic cell origin (CD1c+, CD11c+, MHC II+, no expression of CD11d and lymphoid markers). To the authors' knowledge, this is the first report of canine dendritic cell leukemia-in this instance accompanied by marked tissue infiltration.  相似文献   

14.
The in vitro generation of dendritic cells (DCs) from either blood or bone marrow has been accomplished for humans and a number of other species. This ability has facilitated the opportunity to test the efficacy of DC vaccines in various tumor models. The cottontail rabbit papillomavirus (CRPV) model is the most clinically relevant animal model for human papillomavirus (HPV)-associated carcinogenesis. The CRPV model has been used to test various preventative and therapeutic vaccination strategies, and the availability of rabbit DCs would further expand its utility. However, to date, rabbit DCs have not been phenotypically and/or functionally characterized. Here we show that DCs can be generated in vitro from rabbit bone marrow mononuclear cells (BMMCs) cultured in the presence of the human cytokines GM-CSF and IL-4 and matured with lipopolysaccharide (LPS). These cells show upregulation of MHC class II and CD86, as well as downregulation of CD14, do not have non-specific esterase activity, are able to perform receptor-mediated endocytosis, and are potent stimulators of allogeneic T cell proliferation in mixed lymphocyte reactions. The ability to generate rabbit DCs makes it possible to test the efficacy of DC vaccination in the prevention and treatment of CRPV-induced lesions, which may provide useful preclinical data regarding the use of DC vaccines for HPV-associated lesions, including cervical cancer.  相似文献   

15.
Dendritic cells (DCs), which differentiate in vitro from peripheral blood monocytes (PBMOs) or bone marrow precursors, are a promising candidate for immunotherapy against cancer. The dog, which suffers common types of cancers along with humans, make an ideal large animal model for cancer studies. Monocyte-derived DCs in the dog have not been well characterized, however, since the appropriate condition for in vitro differentiation has not been established. To tackle this problem, we have developed a conditioned media by culturing T cells with immobilized anti-canine CD3 antibody, and sought to induce differentiation of DCs from PBMOs. When purified CD14+ PBMOs were cultured in the presence of 25% T cell conditioned medium (TCCM), the PBMOs increased size and had extended dendritic processes by day 12 of the culture. The cultured PBMOs were found to increase the expression of MHC class II and CD1a molecules, and significantly increased stimulatory activity for allogeneic T cells in the mixed leukocyte reaction. Moreover, the cells significantly increased their expression of IL-18 and IFN-gamma when stimulated with polyinosinic-polycytidylic acid (Poly (I:C)). The cells have a reduced phagocytic activity, which is a common defect in mature DCs. It follows from these results that TCCM does induce the differentiation of DCs from PBMOs.  相似文献   

16.
The objective of this study was to compare nucleated cell fractions and mesenchymal stromal cells (MSCs) from adipose tissue to bone marrow processed by a point-of-care device that are available for immediate implantation. A paired comparison using adipose and bone marrow from five horses was done. The number of nucleated cells, viability, total adherent cells on day 6 of culture and colony-forming unit fibroblasts (CFU-Fs) were determined. Gene expression for markers of stemness, adipogenic, chondrogenic, osteogenic lineage, and collagen formation was measured in total RNA isolated from adherent adipose and bone marrow cells. Day 6 adherent adipose-derived MSC was frozen briefly, whereas day 6 adherent bone marrow–derived MSC was passaged two additional times to obtain adequate cell numbers for chondrogenic, osteogenic, and adipogenic cell differentiation assays. The total cell count per gram was significantly greater for bone marrow, whereas total adherent cells per gram and the CFU-F per million nucleated cells on day 6 were significantly greater for the adipose. In undifferentiated adherent cells, relative gene expression for CD34, adipogenic, and chondrogenic markers and collagen II was significantly lower in the adipose-derived cells. Conversely, expression of collagen I was significantly higher in the undifferentiated adipose-derived cells. Cell density and total RNA were higher in differentiated adipogenic and osteogenic cultures of adipose cells and in chondrogenic cultures of bone marrow cells. This cell preparation method provides a stromal vascular fraction with a large proportion of multipotent MSCs. There are differences in the cells obtained from the two sources. This method can provide an adequate number of multipotent cells from adipose tissue for immediate implantation.  相似文献   

17.
Canine histiocytic proliferative disorders include a wide spectrum of diseases characterized by different biologic behaviors. The etiology and pathogenesis of these diseases are largely unknown. The clinicopathologic, morphologic and immunophenotypic characteristics of canine localized and disseminated histiocytic sarcoma were examined in 39 dogs. Rottweilers, Bernese Mountain Dogs, and retrievers were most commonly affected (79%). Localized histiocytic sarcomas (19 dogs) arose from a single site, and metastatic lesions were observed in draining lymph nodes. Predilection sites were subcutis and underlying tissues on extremities, but tumors occurred in other locations, including spleen, lung, brain, nasal cavity, and bone marrow. Disseminated histiocytic sarcomas (20 dogs), a multisystem disease previously described as malignant histiocytosis, primarily affected spleen, lungs, bone marrow, liver, and lymph nodes. Both localized and disseminated canine histiocytic sarcomas were composed of pleomorphic tumor cell populations. CD1+, CD4-, CD11c+, CD11d-, MHC II+, ICAM-1 +, Thy-1 +/- tumor cells were identified in all snap-frozen samples (31 dogs). This phenotype is characteristic for myeloid dendritic antigen-presenting cell lineage. Hence, canine localized and disseminated histiocytic sarcomas are likely myeloid dendritic cell sarcomas. Dendritic antigen-presenting cells are a heterogeneous cell population with regards to their ontogeny, phenotype, function, and localization. The exact sublineage of the proliferating dendritic antigen-presenting cells involved in canine histiocytic sarcomas remains to be determined. Phenotypic analysis of formalin-fixed tissues from eight dogs was limited by available markers. Morphologic features and the phenotype CD18+, CD3-, and CD79a- were the most useful criteria to indicate likely histiocytic origin.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号